ÖZET
Amaç:
Pandeminin ilk dört aylık döneminde koronavirüs hastalığı-2019 (COVİD-19) şüphesiyle, COVİD-19 YBÜ’lerine kabul edilen hastalar tanılarına ve dönemlere göre karşılaştırıldı.
Gereç ve Yöntem:
Tek merkezde aynı algoritma ile COVİD-19 YBÜ’ye kabul edilen 1,430 hasta verisi retrospektif olarak kaydedildi. Hastalar polimeraz zincirleme reaksiyonu sonucu ile radyolojik ve klinik bulgulara göre COVİD-19 ve non-COVİD-19 hastalar olarak sınıflandırıldılar. Ayrıca COVİD-19 hastaları mortalite ve sağkalım açısından da karşılaştırıldı. Bunun yanında, pandeminin başlangıcı ve normalleşme döneminde COVİD-19 YBÜ’lerine kabul edilen hastaların verileri değerlendirildi.
Bulgular:
Çalışmaya alınan 1,430 hastanın 630’u COVİD-19, 800’ü non-COVİD-19 gruptaydı. Yaş ortalamalarında anlamlı bir farklılık bulunurken, cinsiyetler arasında bir farklılık yoktu (p=0,001, p=0,262). COVİD-19 ölen grubun yaş ortalaması yaşayan gruptan daha yüksekti (p<0,001). En sık başvuru semptomu dispne (%51,2), en sık eşlik eden komorbidite hipertansiyon (%51,2) idi. Normalleşme döneminde “COVİD-19” tanısı ile yoğun bakıma kabul edilen hasta oranı ve yoğun bakımda mortalite oranı daha fazlaydı.
Sonuç:
Pandemi başlangıç dönemi hayatımıza bir bilinmez olarak giren COVİD-19’u anlayabilmekle geçti ve aynı zamanda toplumu ve sağlık çalışanlarını koruyarak hastaları daha etkin bir şekilde tedavi etmemiz için yol gösterici bir periyod oldu.
References
1
Last JM: A dictionary of epidemiology, 4th edition. Oxford University Press; New York: 2001.
2
Republic Of Turkey Ministry Covıd-19 Information Page [serial online] 2020 Available froms URL https://covid19.saglik.gov.tr
3
Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8:506-17.
4
Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology 2020;551:1-9.
5
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;323:1612-4.
6
Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A , et al. Clinical Characteristics and Morbidity Associated WithCoronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open 2020;3:e2012270.
7
WHO: Health workforce policy and management in the context of the COVID-19 pandemic response: interim guidance [serial online] 2020 Available from:s URL https://apps.who.int/iris/bitstream/handle/10665/337333/WHO-2019-nCoV-health_workforce-2020.1-eng.pdf?sequence=1&isAllowed=yAccessed December 3, 2020.
8
Peng M, Qian Z, Zhang L. Care for Critical Ill Patients With COVID-19: Establishment of a Temporary Intensive Care Unit in an Isolated Hospital. Front Med 2020.
9
Zangrillo A, Beretta L, Silvani P, Colombo S, Scandroglio AM, Dell’Acqua A, et al. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency. Crit Care Resusc 2020;22:91-4.
10
Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, et al. COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med 2020;46:2035-47.
11
Socolovithc RL, Fumis RRL, Tomazini BM, Pastore L, Galas FRBG, de Azevedo LCP, et al. Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study. PLoS ONE 2020;15:e0243269.
12
Burrell AJ, Pellegrini B, Salimi F, Begum H, Broadley T, Campbell LT, et al. Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic. Med J Aust 2021;214:23-30.
13
Thomson RJ, Hunter J, Dutton J, Schneider J, Khosravi M, Casement A, et al. Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study. PLOS ONE 2020:15:e0243710.
14
Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020;180:1345-55.
15
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 2021;54:12-6.
16
Chand S, Kapoor S, Orsi D, Fazzari MJ, Tanner TG, Umeh GC, et al. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center. J Intensive Care Med 2020;35:963-70.
17
Scientific Brief: SARS-CoV-2 Transmission. CDC [serial online] 2021 Available from: s URL https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.htmlAccessed May 7,2021.
18
Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med 2020;132:749-55.
19
Ng WH, Tipih T, Makoah NA, Vermeulen JG, Goedhals D, Sempa JB, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio 2021;12:e03647-20.
20
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-5.
21
Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era. Radiology 2020;297:E289-302.
22
Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev 2021;26:1-10.
23
Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 2021;17:71-2.
24
Alhazzani W, Evans L, Alshamsi F, Møller MH, Ostermann M, Prescott HC, et al. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med 2021;49:e219-34.
25
Mitra AR, Fergusson NA, Lloyd-Smith E, Wormsbecker A, Foster D, Karpov A, et al. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ 2020;192:E694-701.
26
Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. Am J Respir Crit Care Med 2020;201:1430-4.
27
Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020;11:6317.
28
Dramé M, Tabue Teguo M, Proye E, Hequet F, Hentzien M, Kanagaratnam L, et al. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J Med Virol 2020;92:2312-3.
29
Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol 2020;126:108961.
30
He G, Han Y, Fang Q, Zhou J, Shen J, Li T, et al. [Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020;49:232-9.
